Skip to main content
Log in

Dexmedetomidine as sole agent for awake fiberoptic intubation in a patient with local anesthetic allergy

  • Clinical Report
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

A series of case reports acknowledges the efficacy of dexmedetomidine as a sole sedative for awake intubations in managing a critical airway. However, most case reports documented in the literature used topicalization of the oropharynx either via nebulized lidocaine or the spray-as-you-go technique with either 2% or 4% lidocaine spray to achieve successful intubation. The following case report presents an intensive care unit (ICU) patient with a critical airway who had a true documented allergy to local anesthetics. This case report demonstrates that dexmedetomidine appears to be useful for sedation during awake intubations in critical airways, without the need for airway topicalization. The ability of dexmedetomidine to act as a sedative, anxiolytic, analgesic, and antisialagogue without causing respiratory depression is promising to the field of anesthesiology. Additional studies are needed to elucidate its potential role as the sole agent for awake fiberoptic intubation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adbelmalak B, Makary L, Hoban J, et al. Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. J Clin Anesth. 2007;19:370–3.

    Article  Google Scholar 

  2. Ramsay MAE, Luterman DL. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004;101:787–90.

    Article  PubMed  Google Scholar 

  3. Venn RM, Hell J, Grounds RM, et al. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4:302–8.

    Article  PubMed  CAS  Google Scholar 

  4. Bergese SD, Khabiri B, Roberts WD, et al. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth. 2007;19:141–4.

    Article  PubMed  CAS  Google Scholar 

  5. Xue FS, Liu HP, Nong H, et al. Spray-as-you-go airway topical anesthesia in patients with a difficult airway: a randomized, double-blind comparison of 2% and 4% lidocaine. Anesth Analg. 2009;108:536–43.

    Article  PubMed  Google Scholar 

  6. Grant SA, Breslin DS, MacLeod DB, et al. Dexmedetomidine infusion for sedation during fiberoptic intubation. J Clin Anesth. 2004;16:124–6.

    Article  PubMed  CAS  Google Scholar 

  7. Tobias JD. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2007;8:115–27.

    Article  PubMed  Google Scholar 

  8. Panzer O, Moitra V, Sladen RN, et al. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripherals mu antagonists. Crit Care Clin. 2009;25:451–69.

    Article  PubMed  CAS  Google Scholar 

  9. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother. 2007;41:245–52.

    Article  PubMed  CAS  Google Scholar 

  10. Cohen IL, Gallagher TJ, Pohlman AS, et al. Management of the agitated intensive care unit patient. Crit Care Med. 2002;30:97–123.

    Article  Google Scholar 

  11. Arpino PA, Kalafatas K, Thompson BT, et al. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit. J Clin Pharm Ther. 2008;33:25–30.

    Article  PubMed  CAS  Google Scholar 

  12. Kamibayashi MM. Clinical uses of alpha-2 adrenergic agonists. Anesthesiology. 2000;93:1345.

    Article  PubMed  CAS  Google Scholar 

  13. Arain SR, Ruehlow RM, Uhrich TD, et al. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg. 2004;98:153–8.

    Article  PubMed  CAS  Google Scholar 

  14. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382–94.

    Article  PubMed  CAS  Google Scholar 

  15. De Jonghe B, Cook D, Appere-De-Vecchi C, et al. Using and understanding sedation scoring systems: a systematic review. Intensive Care Med. 2000;26:275–85.

    Article  PubMed  Google Scholar 

  16. Ramsay MAE, Savege TM, Simpson BRJ, et al. Controlled sedation with alphaxalone–alphadolone. BMJ. 1974;2:656–9.

    Article  PubMed  CAS  Google Scholar 

  17. De Wolf AM, Fragen RJ, Avram MJ, et al. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg. 2001;93:1205–9.

    Article  PubMed  Google Scholar 

  18. Bloor BC, Ward DS, Belleville JP, et al. Effects of intravenous dexmedetomidine in humans, II: hemodynamic changes. Anesthesiology. 1992;77:1134–42.

    Article  PubMed  CAS  Google Scholar 

  19. Scheinin B, Lindgren AM, Randell T, et al. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and the need for thiopentone and perioperative fentanyl. Br J Anesth. 1992;68:126.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maxime Madhere.

About this article

Cite this article

Madhere, M., Vangura, D. & Saidov, A. Dexmedetomidine as sole agent for awake fiberoptic intubation in a patient with local anesthetic allergy. J Anesth 25, 592–594 (2011). https://doi.org/10.1007/s00540-011-1154-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-011-1154-z

Keywords

Navigation